Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 74

1 79. Heitner JF, Senthilkumar A, Harrison JK, et al. Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2019; e007305.

2 80. Sardella G, Lucisano L, Garbo R, et al. Single-staged compared with multi-staged PCI in multivessel NSTEMI patients. The SMILE trial. J Am Coll Cardiol 2016; 67(3): 264–272. Total cardiovascular events are reduced with single-staged PCI, mainly through a reduction of target vessel revascularization and death <not MI> (this may be related to the longer ischemic time with multi-staged PCI, particularly when the culprit lesion is not properly identified. Also, there is a potential harm of repeating procedures, bleeding, repeat ischemia?).

3 81. Hannan EL, Samadashvili Z, Walford G, et al. Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv 2013; 6: 12–20.

4 82. Rathod KS, Koganti S, Jain AK, et al. Complete versus culprit-only lesion intervention in patients with acute coronary syndromes. J Am Coll Cardiol 2018;72:1989-1999 (British national registry analysis). + Also: Brener SJ, Milford-Beland S, Roe MT, et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J 2008; 155: 140–6.

5 83. Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381:1411–1421

6 84. Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open label, randomized controlled trial. Lancet 2015; 386: 665–671.